WASHINGTON, D.C. (August 16, 2022) – The Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Stephen J. Ubl released the following statement after the president signed into law the Inflation Reduction Act, which includes a proposal that would allow the government to set prices for prescription medicines:
A group of Democratic lawmakers and independent Sen. Bernie Sanders (Vt.) on Tuesday called on the pharmaceutical industry to answer questions regarding the recent rise in drug prices.